UNLV, SNWA Study Makes Case for Candida Auris Wastewater Surveillance

A rapid spike in cases of a potentially deadly, drug-resistant fungus has concerned public health officials across the nation. But a team of Southern Nevada researchers hope their new study applying wastewater surveillance can help health officials get a step ahead of this emerging global public health threat.

HOW WILL HUMANS SURVIVE A GLOBAL CATASTROPHE?

One suggested way to save humankind in the event of a deadly pandemic or other extreme global catastrophe is establishing a safe refuge – on an island or in such far-out places as the moon or under water — where a portion of the human population can stay alive.

Cleveland Clinic Appoints Ted Ross, Ph.D., as Global Director of Vaccine Development

Ted Ross, Ph.D., has been appointed Global Director of Vaccine Development at Cleveland Clinic.

In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19. A highly renowned scientist with expertise in virology, vaccines, immunology and microbiology, Dr. Ross’ research focuses on the design of new vaccines and the implementation of new vaccine trials.

UF/IFAS scientists record first case of harmful bacteria in ubiquitous weed found throughout U.S.

Scientists at the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) have recorded the first North American case of a harmful phytoplasma disease known for its threat to fruit, vegetable and ornamental crops in South America and the Middle East. These same crops are economically important to Florida and in parts of the U.S. To make matters worse, scientists confirmed the host for the disease to be one of the most noxious and rapidly spreading weeds commonly found in a wide range of environments throughout the United States and into Canada.

Population-specific diversity within fungi species could enable improved drug discovery

Scientists at Oak Ridge National Laboratory and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in medicine, industry and agriculture.

Cleveland Clinic and IBM Unveil Landmark 10-Year Partnership to Accelerate Discovery in Healthcare and Life Sciences

Armonk, N.Y. and Cleveland, OH, March 30, 2021: Cleveland Clinic and IBM have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic – IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and life sciences through the use of high performance computing on the hybrid cloud, artificial intelligence (AI) and quantum computing technologies.

Reusable, foldable and sterilisable ‘shield’ developed by NUS-NUH team provides additional protection for healthcare workers caring for COVID-19 patients

A research team from the National University of Singapore and the National University Hospital has developed a reusable protective barrier which lowers the risk of frontline healthcare workers being exposed to COVID-19 via droplets and aerosols when they look after patients.

Cleveland Clinic Establishes Center for Global and Emerging Pathogens Research

Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.

The new center has been in the planning stages for 18 months and will span Cleveland Clinic’s Lerner Research Institute and the soon-to-open Cleveland Clinic Florida Research and Innovation Center (FRIC) in Port St. Lucie, Florida.